Dr. Wei Lai
魏来
Chief Physician; Professor; Former Director of the Peking University Hepatology Institute; Former Vice President of Peking University People's Hospital
Where they practice, who they consult.
- Peking University People's Hospital, Peking University, Beijing
- 35+ years in hepatology and infectious disease
- English, Mandarin
What they personally lead.
Training and recognition
Led China's first Phase III clinical trial of all-oral direct-acting antiviral drugs for hepatitis C; the only Asian hepatologist invited to co-author the American KDIGO guidelines on hepatitis C in chronic kidney disease; elected Executive Committee Member of the Asian Pacific Association for the Study of the Liver (APASL); established patient education networks for viral hepatitis across China; former Chair-elect of the Chinese Medical Association Hepatology Branch; developed hepatitis C screening standards adopted nationally
What to expect
Dr. Wei is one of China's foremost hepatitis C experts. Patients with chronic hepatitis B or C seeking the latest antiviral treatment protocols will benefit from his expertise. Note that Dr. Wei has also served at Beijing Tsinghua Changgung Hospital; patients should verify his current consultation schedule before booking.
Check the public record
Look up publications, citations, and academic profile on independent platforms before reaching out.
Results are automated searches and may include other individuals with similar names.
Ask the AI or request a coordinator.
The AI can compare Wei Lai's background to other specialists in Beijing. A coordinator can confirm appointment availability and English-language support.
Information is provided for reference only and may not reflect current conditions. Verify directly with the hospital before making decisions.